Free and complexed interleukin-8 in blood and bronchial mucosa in asthma.

We have tested the hypothesis that the expression of interleukin-8 (IL-8) is increased in bronchial tissue and circulating leukocytes of atopic asthmatics, indicating a role for this chemokine in asthma. The concentration of IL-8 in its free form and complexed with IgG or IgA was measured by ELISA in bronchial tissue, serum, and lysates of freshly isolated peripheral blood mononuclear cells and granulocytes from subjects with mild or severe asthma and nonatopic nonasthmatic subjects. Serum ECP was measured by fluorescent enzyme immunoassay. Free IL-8 was detected in the sera (n = 44) and bronchial tissue (n = 9) of all subjects with severe atopic asthma, but it was undetectable in normal subjects and subjects with mild atopic asthma, suggesting that free IL-8 is a marker of severe asthma. A positive correlation between free IL-8 and serum ECP levels found in severe disease suggests that IL-8 is associated with eosinophil activation. Complexes of IL-8 with IgA and IgG were detected in all serum and tissue samples. However, the levels of the IL-8-IgA complex were increased in the bronchial mucosa in asthma, and in blood were related to disease activity. Together, these results point to upregulation of IL-8 production in asthma and the induction of IL-8 binding immunoglobulins of the IgA class in the inflamed mucosa. We suggest a proinflammatory role for these complexes in lung tissue.

[1]  Konrad M. Hartung,et al.  IL-8 is expressed by human peripheral blood eosinophils. Evidence for increased secretion in asthma. , 1995, Journal of immunology.

[2]  R. Djukanović,et al.  Mucosal IgA is an important moderator of eosinophil responses to tissue-derived chemoattractants. , 1995, International archives of allergy and immunology.

[3]  Kwang Woo Kim,et al.  Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. , 1995, The Journal of allergy and clinical immunology.

[4]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[5]  P. Howarth,et al.  Mucosal inflammation and asthma. , 1994, American journal of respiratory and critical care medicine.

[6]  R. Braun,et al.  Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. , 1994, American journal of respiratory and critical care medicine.

[7]  P. Howarth,et al.  Influence of interleukin-8 challenge in the nasal mucosa in atopic and nonatopic subjects. , 1994, American journal of respiratory and critical care medicine.

[8]  C. Mason,et al.  Loss of compartmentalization of alveolar tumor necrosis factor after lung injury. , 1994, American journal of respiratory and critical care medicine.

[9]  J. Shute,et al.  Interleukin‐8 is a potent eosinophil chemo‐attractant , 1994, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[10]  B. Dewald,et al.  Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. , 1994, Advances in immunology.

[11]  J. Shute,et al.  Autoantibodies to IL-8 in bronchoalveolar lavage fluid from normal and asthmatic individuals , 1993 .

[12]  J. Shelhamer,et al.  Corticosteroids differentially regulate secretion of IL-6, IL-8, and G-CSF by a human bronchial epithelial cell line. , 1993, The American journal of physiology.

[13]  R. Danner,et al.  Neutrophil attractant protein-1 and monocyte chemoattractant protein-1 in human serum. Effects of intravenous lipopolysaccharide on free attractants, specific IgG autoantibodies and immune complexes. , 1993, Journal of immunology.

[14]  J. Warner,et al.  Interleukin-8 Concentrations Are Elevated in Bronchoalveolar Lavage, Sputum, and Sera of Children with Cystic Fibrosis , 1993, Pediatric Research.

[15]  G. D. Martich,et al.  Compartmentalization of the acute cytokine response in humans after intravenous endotoxin administration. , 1993, Journal of applied physiology.

[16]  P. Jorens,et al.  Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. , 1993, The American journal of physiology.

[17]  R. Strieter,et al.  Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups , 1993, The Lancet.

[18]  J. Crabtree,et al.  Gastric Interleukin‐8 and IgA IL‐8 Autoantibodies in Helicobacter pylori Infection , 1993, Scandinavian journal of immunology.

[19]  C E Reed,et al.  Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? , 1993, The American review of respiratory disease.

[20]  J. Hoeffel,et al.  Interleukin-8 is a major neutrophil chemotactic factor in pleural liquid of patients with empyema. , 1992, The American review of respiratory disease.

[21]  T. Standiford,et al.  IL-7 up-regulates the expression of IL-8 from resting and stimulated human blood monocytes. , 1992, Journal of immunology.

[22]  E. Leonard,et al.  Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum. , 1992, The Journal of clinical investigation.

[23]  S. Mattoli,et al.  Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. , 1992, The Journal of allergy and clinical immunology.

[24]  M. Ceska,et al.  Human neutrophil activating peptide/interleukin 8 acts as an autoantigen in rheumatoid arthritis. , 1992, Annals of the rheumatic diseases.

[25]  P. Howarth,et al.  The safety aspects of fiberoptic bronchoscopy, bronchoalveolar lavage, and endobronchial biopsy in asthma. , 1991, The American review of respiratory disease.

[26]  S. Holgate,et al.  The role of the eosinophil in asthma. , 1991, The American review of respiratory disease.

[27]  T. Standiford,et al.  Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. , 1991, Experimental lung research.

[28]  R. Djukanović,et al.  Mucosal inflammation in asthma. , 1990, The American review of respiratory disease.

[29]  T. Standiford,et al.  Disparate gene expression of chemotactic cytokines by human mononuclear phagocytes. , 1990, Biochemical and biophysical research communications.

[30]  H. Kita,et al.  Regulatory effect of cytokines on eosinophil degranulation. , 1990, Journal of immunology.

[31]  K. Matsushima,et al.  Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. , 1989, Journal of immunology.

[32]  B. Dewald,et al.  Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil-activating factor: biological equivalence between natural and recombinant neutrophil-activating factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[33]  D. Burnett.  Immunoglobulins in the lung. , 1986, Thorax.